GlaxoSmithKline plc - Result of AGM
GlaxoSmithKline plc (GSK) announces that at its Annual General Meeting (AGM) today, all resolutions were passed by shareholders.
GlaxoSmithKline AGM Poll Results
The following table shows the votes cast for each resolution:
Resolution |
Total votes for* |
% |
Total votes against |
% |
Total votes cast |
Votes withheld** |
|
1 |
Adoption of Directors' Report and Financial Statements |
3,547,982,735 |
98.85 |
41,278,849 |
1.15 |
3,589,261,584 |
10,176,355 |
2 |
Approval of the Remuneration Report |
3,377,865,669 |
98.52 |
50,641,769 |
1.48 |
3,428,507,438 |
170,934,805 |
3
|
Approval of the Directors' Remuneration Policy |
3,408,815,630 |
97.42 |
90,250,943 |
2.58 |
3,499,066,573 |
100,375,670 |
4 |
Re-election of Sir Christopher Gent |
3,439,528,694 |
95.90 |
147,149,979 |
4.10 |
3,586,678,673 |
12,768,786 |
5 |
Re-election of Sir Andrew Witty |
3,578,767,397 |
99.72 |
10,010,466 |
0.28 |
3,588,777,863 |
10,669,596 |
6 |
Re-election of Professor Sir Roy Anderson |
3,579,231,977 |
99.74 |
9,439,851 |
0.26 |
3,588,671,828 |
10,774,711 |
7 |
Re-election of Dr Stephanie Burns |
3,576,112,095 |
99.65 |
12,610,100 |
0.35 |
3,588,722,195 |
10,724,344 |
8 |
Re-election of Stacey Cartwright |
3,568,976,499 |
99.45 |
19,694,382 |
0.55 |
3,588,670,881 |
10,775,379 |
9 |
Re-election of Simon Dingemans |
3,542,608,802 |
98.72 |
45,996,505 |
1.28 |
3,588,605,307 |
10,841,886 |
10 |
Re-election of Lynn Elsenhans |
3,585,307,313 |
99.91 |
3,293,782 |
0.09 |
3,588,601,095 |
10,845,444 |
11 |
Re-election of Judy Lewent |
3,549,394,841 |
98.91 |
39,226,163 |
1.09 |
3,588,621,004 |
10,825,535 |
12 |
Re-election of Sir Deryck Maughan |
3,561,179,474 |
99.24 |
27,416,814 |
0.76 |
3,588,596,288 |
10,850,250 |
13 |
Re-election of Dr Daniel Podolsky |
3,579,219,741 |
99.74 |
9,358,778 |
0.26 |
3,588,578,519 |
10,868,020 |
14 |
Re-election of Dr Moncef Slaoui |
3,574,560,380 |
99.61 |
14,055,744 |
0.39 |
3,588,616,124 |
10,831,335 |
15 |
Re-election of Tom de Swaan
|
3,525,650,902 |
98.30 |
61,002,251 |
1.70 |
3,586,653,153 |
12,793,386 |
16 |
Re-election of Jing Ulrich |
3,585,201,858 |
99.91 |
3,322,988 |
0.09 |
3,588,524,846 |
10,921,427 |
17 |
Re-election of Hans Wijers |
3,280,229,504 |
91.57 |
301,809,653 |
8.43 |
3,582,039,157 |
17,407,382 |
18 |
Re-appointment of auditors |
3,503,022,193 |
98.93 |
37,982,934 |
1.07 |
3,541,005,127 |
58,441,412 |
19 |
Remuneration of auditors |
3,520,845,776 |
99.32 |
23,984,857 |
0.68 |
3,544,830,633 |
54,615,906 |
20 |
Authority for the company to make donations to political organisations and incur political expenditure |
3,498,414,617 |
97.67 |
83,465,800 |
2.33 |
3,581,880,417 |
17,567,042 |
21 |
Authority to allot shares |
3,478,465,018 |
97.01 |
107,214,629 |
2.99 |
3,585,679,647 |
13,766,892 |
22 |
Disapplication of pre-emption rights*** |
3,497,328,599 |
97.60 |
85,983,069 |
2.40 |
3,583,311,668 |
16,135,585 |
23 |
Authority for the company to purchase its own shares*** |
3,578,605,038 |
99.73 |
9,538,332 |
0.27 |
3,588,143,370 |
11,302,119 |
24 |
Exemption from statement of senior statutory auditor's name |
3,568,553,870 |
99.57 |
15,538,722 |
0.43 |
3,584,092,592 |
15,354,867 |
25 |
Authorise reduced notice of a general meeting other than an AGM*** |
3,204,747,061 |
89.37 |
381,205,594 |
10.63 |
3,585,952,655 |
13,494,803 |
Sir Robert Wilson did not stand for re-election as a Director, and has stepped down from the Board with effect from the conclusion of the AGM.
The following table provides further relevant information:
|
GlaxoSmithKline's Fourteenth AGM (2014)
|
GlaxoSmithKline's Thirteenth AGM (2013)
|
Issued share capital (excluding Treasury Shares) |
4,861,007,167 |
4,922,724,518 |
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares) |
74.05% |
76.50% |
Total shareholder population |
140,792 |
144,196 |
Total number of proxies lodged |
8,333 |
8,931 |
% of shareholders who lodged proxies |
5.92% |
6.19% |
Number of shareholders, corporate representatives and proxies who attended the AGM |
429 |
442 |
In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business at an annual general meeting will be submitted to the UK Listing Authority and will in due course be available for inspection at www.morningstar.co.uk/uk/NSM and on the company's website at http://www.gsk.com/investors/shareholder-information/annual-general-meeting.html
Notes:
* Includes discretionary votes.
** A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
*** Indicates Special Resolutions requiring a 75% majority.
V A Whyte
Company Secretary
7 May 2014
GSK enquiries: |
|
|
|
UK Media enquiries: |
David Mawdsley |
+44 (0) 20 8047 5502 |
(London) |
|
Simon Steel |
+44 (0) 20 8047 5502 |
(London) |
|
David Daley |
+44 (0) 20 8047 5502 |
(London) |
|
Catherine Hartley |
+44 (0) 20 8047 5502 |
(London) |
|
Sarah Spencer |
+44 (0) 20 8047 5502 |
(London) |
|
|
|
|
US Media enquiries: |
Stephen Rea |
+1 215 751 4394 |
(Philadelphia) |
|
Melinda Stubbee |
+1 919 483 2510 |
(North Carolina) |
|
Mary Anne Rhyne |
+1 919 483 0492 |
(North Carolina) |
|
Emily Beamer |
+1 215 751 6622 |
(Philadelphia) |
|
Jennifer Armstrong |
+1 215 751 5664 |
(Philadelphia) |
|
|
|
|
Analyst/Investor enquiries: |
Ziba Shamsi |
+44 (0) 20 8047 5543 |
(London) |
|
Kirsty Collins (SRI & CG) |
+44 (0) 20 8047 5534 |
(London) |
|
Tom Curry |
+ 1 215 751 5419 |
(Philadelphia) |
|
Gary Davies |
+44 (0) 20 8047 5503 |
(London) |
|
James Dodwell |
+44 (0) 20 8047 2406 |
(London) |
|
Jeff McLaughlin |
+1 215 751 7002 |
(Philadelphia) |
|
Lucy Singah |
+44 (0) 20 8047 2248 |
(London) |